Stem cell tracking: Reversing the silence of the lambs...

Journal of Nuclear Medicine

Volumn 46, Issue 2, 2005, Pages 200-203

  Boersma, Hendrikus H ^a   Tromp, Selma C ^a   Hofstra, Leonard ^a   Narula, Jagat ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; COPPER 64; F 18 6 FLUORO LEVODOPA; IODINE 123; IOFLUPANE; LEVODOPA; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA [4 IODOPHENYL]NORTROPANE; PYRUVALDEHYDE BIS(N 4 METHYLTHIOSEMICARBAZONE); RADIOISOTOPE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; BLOOD TRANSFUSION; BRAIN CELL; BRAIN TRANSPLANTATION; CELL DEGENERATION; CELL FUNCTION; CELL LABELING; FLUORESCENCE; HUMAN; MESENCEPHALON; NERVE CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; REINNERVATION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; XENOGRAFT; ANIMAL; CELL COUNT; CELL MOTION; CELL SEPARATION; GENETIC ENGINEERING; ISOTOPE LABELING; METHODOLOGY; NOTE; PHYSIOLOGY; SCINTISCANNING;

ANIMALS; CELL COUNT; CELL MOVEMENT; CELL SEPARATION; GENETIC ENGINEERING; HUMANS; ISOTOPE LABELING; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 15844377104     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Reutelingsperger CP, Dumont E, Thimister PW, et al. Visualization of cell death in vivo with the annexin A5 imaging protocol. J Immunol Methods. 2002;265:123-132.
2. Chandrashekhar Y, Narula J. Death hath a thousand doors to let out life. Circ Res. 2003;92: 710-714.
3. Clarke CE. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Lancet Neurol. 2004;3:466-474.
4. Citron M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci. 2004;5: 677-685.
5. Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet. 2004;364:200-202.
6. Rebulla P, Giordano R. Cell therapy: an evolutionary development of transfusion medicine. Int J Cardiol. 2004;95(suppl 1):S38-S42.
7. Bjarkam CR, Sorensen JC. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease. Biol Psychiatry. 2004;56:213-216.
8. de Wert G, Mummery C. Human embryonic stem cells: research, ethics and policy. Hum Reprod. 2003;18:672-682.
9. Bjorklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2003;2:437-445.
10. Hammerstad J, Hogarth P. Parkinson's disease: surgical options. Curr Neurol Neurosci Rep. 2001;1:313-319.
11. Piccini P, Brooks DJ, Bjorklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci. 1999;2:1137-1140.
12. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001; 344:710-719.
13. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003;54:403-414.
14. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders: how to make it work. Nat Med. 2004; 10(suppl):S42-S50.
15. Jendelova P, Herynek V, Urdzikova L, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res. 2004;76:232-243.
16. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002;17:803-811.
17. 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA. 2002;99:3030-3035.
18. Herschman HR. PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. Crit Rev Oncol Hematol. 2004;51:191-204.
19. Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord. 2003;18(suppl 7):S43-S51.
20. Marek K, Jennings D, Seibyl J. Do dopamine agonists or levodopa modify Parkinson's disease progression? Eur J Neurol. 2002;9(suppl 3):15-22.
21. Yau TM, Tomita S, Weisel RD, et al. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg. 2003;75:169-176.
22. Kim YH, Lee DS, Kang JH, et al. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med. 2005;46:305-311.
23. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457-463.
24. Cattaneo E, Conti L. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res. 1998; 53:223-234.
25. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004;113:1701-1710.